Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
120
currently held
Exits tracked
78
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
HgCapital TrustadminNew Director · Appointment of ALI, Moynul as director · New director appointed · board evolution4 days agoNew Director · Appointment of ALI, Moynul as director · New director appointed · board evolution
adminTreble PeakcapitalShare Allotment · Statement of capital following allotment of shares · New shares issued · investment or fundraising signal5 days agoShare Allotment · Statement of capital following allotment of shares · New shares issued · investment or fundraising signal
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capital
Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks agoCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminCompagnie Financière et de Participations RoullieradminBoard change · Management board member change:: ROULLIER Roxane, Marie-Thérèse · Change in the management board2 weeks agoBoard change · Management board member change:: ROULLIER Roxane, Marie-Thérèse · Change in the management board
adminLauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month agoBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin167 companies matching · Page 1 of 4
Pantherna Therapeutics
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2019
Hold
7yr
Exit
2026
to T-CURX
CureVac
dievini Hopp BioTech holding (Evergreen Balance Sheet)
GermanySector
Biotech
Investordievini Hopp BioTech holding
Entry
2005
Hold
20yr
Exit
2025
to BioNTech
GQ Bio Therapeutics
Innovationsstarter Fonds Hamburg I
GermanySector
Biotech
InvestorIFB Innovationsstarter
Entry
2012
Hold
13yr
Exit
2025
to Pacira BioSciences
Dynamic Biosensors
Seedfonds Bayern
GermanySector
Biotech
InvestorBayern Kapital
Entry
2012
Hold
12yr
Owners
3
Exit
2024
to Bruker
Cardior Pharmaceuticals
coparion
GermanySector
Biotech
Investorcoparion
Entry
2021
Hold
3yr
Owners
2
Exit
2024
to Novo Nordisk
CARDIOR
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2017
Hold
7yr
Exit
2024
to Novo Nordisk
Morphosys
Seedfonds Bayern
GermanySector
Biotech
InvestorBayern Kapital
Entry
1996
Hold
28yr
Exit
2024
to Novartis
SensID GmbH
Venture Capital Fonds MV GmbH
GermanySector
Biotech
InvestorGENIUS Venture Capital
Entry
2018
Hold
6yr
Exit
2024
to Microbiologics
Emergence Therapeutics
Gruenderfonds Ruhr I
GermanySector
Biotech
InvestorGruenderfonds Ruhr
Entry
2019
Hold
4yr
Owners
3
Exit
2023
to Eli Lilly
adivo
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2018
Hold
5yr
Exit
2023
to Zoetis
BianoGMP GmbH
Thueringer Startup-Fonds (TSF)
GermanySector
Biotech
Investorbm-t Beteiligungsmanagement Thueringen
Entry
2018
Hold
5yr
Exit
2023
to EUROAPI
c-LEcta
MFT Mittelstands-Fonds Thueringen (MFT)
GermanySector
Biotech
Investorbm-t Beteiligungsmanagement Thueringen
Entry
2006
Hold
16yr
Owners
3
Exit
2022
to Kerry Group
Belyntic
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2019
Hold
3yr
Exit
2022
to Mesa Laboratories
CEVEC Pharmaceuticals
NRW.Venture
GermanySector
Biotech
InvestorNRW.BANK
Entry
2009
Hold
13yr
Exit
2022
to Cytiva
PearlRiver Bio
TVM Life Science Ventures
GermanySector
Biotech
InvestorTVM Capital Life Science
Entry
2020
Hold
2yr
Exit
2022
to Centessa Pharmaceuticals
VAXIMM
Sunstone Life Science Ventures III
GermanySector
Biotech
InvestorSunstone Life Science Ventures
Entry
2011
Hold
11yr
Exit
2022
to NEC OncoImmunity
BioNTech
Athos Evergreen Life Sciences
GermanySector
Biotech
InvestorAthos
Entry
2008
Hold
18yr
Owners
2
JeNaCell
Evonik Venture Capital
GermanySector
Biotech
InvestorEvonik Venture Capital
Entry
2012
Hold
9yr
Owners
3
Exit
2021
to Evonik
Sirion Biotech
Creathor Venture Fund II
GermanySector
Biotech
InvestorCreathor Ventures
Entry
2007
Hold
14yr
Owners
3
Exit
2021
to PerkinElmer (Revvity)
Cube Biotech
MED III
GermanySector
Biotech
InvestorARCHIMED
Entry
2012
Hold
9yr
Owners
2
ALRISE Biosystems
VC Fonds Technologie Berlin
GermanySector
Biotech
InvestorIBB Ventures
Entry
2006
Hold
15yr
Exit
2021
to Ferring
aquila biolabs
Seed Fonds Aachen
GermanySector
Biotech
InvestorS-UBG AG Aachen Krefeld Mönchengladbach
Entry
2015
Hold
6yr
Exit
2021
to Scientific Industries
lophius
S-Refit AG
GermanySector
Biotech
InvestorSobera Capital
Entry
2016
Hold
5yr
Exit
2021
to Mikrogen
Protagen Protein Services (PPS)
ZFHN Zukunftsfonds Heilbronn (D11Z. Ventures Evergreen)
GermanySector
Biotech
InvestorD11Z. Ventures
Entry
2012
Hold
9yr
Exit
2021
to ProtaGene (Ampersand Capital Partners)
Immatics
Athos Evergreen Life Sciences
GermanySector
Biotech
InvestorAthos
Entry
2004
Hold
20yr
Owners
5
m2p-labs
FIDURA Rendite Sicherheit Plus Ethik 3
GermanySector
Biotech
InvestorFIDURA Private Equity Fonds
Entry
2006
Hold
14yr
Owners
3
Exit
2020
to Beckman Coulter
ChromoTek
HTGF I
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2010
Hold
10yr
Owners
2
Exit
2020
to Proteintech Group
Jennewein Biotechnologie
Bioventure Club Deals
GermanySector
Biotech
InvestorBioventure Management
Entry
2012
Hold
8yr
Exit
2020
to Chr. Hansen6.0x
Lipocalyx
HTGF II
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2011
Hold
9yr
Exit
2020
to BioNTech
Myelo Therapeutics
VC Fonds Technologie Berlin
GermanySector
Biotech
InvestorIBB Ventures
Entry
2013
Hold
7yr
Exit
2020
to Eckert & Ziegler
Breath Therapeutics
Gimv Portfolio
GermanySector
Biotech
InvestorGimv
Entry
2016
Hold
3yr
Owners
2
Exit
2019
to Zambon
Immunic
HTGF II
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2016
Hold
3yr
Owners
2
Exit
2019
to Vital Therapies, Inc.
Immunic Therapeutics
IBG Innovationsfonds
GermanySector
Biotech
Investorbmp Ventures AG
Entry
2016
Hold
3yr
Owners
2
Exit
2019
to Vital Therapies, Inc.
Centogene
DPE Fund III
GermanySector
Biotech
InvestorDPE Deutsche Private Equity
Entry
2017
Hold
2yr
Exit
2019
ICD Therapeutics
Boehringer Ingelheim Venture Fund
GermanySector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
–
Exit
2019
to Boehringer Ingelheim
Protagen
NRW.Venture
GermanySector
Biotech
InvestorNRW.BANK
Entry
2010
Hold
9yr
Exit
2019
to Oncimmune
Noxxon Pharma
Sofinnova Capital VI
GermanySector
Biotech
InvestorSofinnova Partners
Entry
1998
Hold
20yr
Owners
2
Exit
2018
Rigontec
Sunstone Life Science Ventures IV
GermanySector
Biotech
InvestorSunstone Life Science Ventures
Entry
2014
Hold
3yr
Owners
5
Exit
2017
to Merck (MSD)
evoxx technologies
NRW.Venture
GermanySector
Biotech
InvestorNRW.BANK
Entry
2013
Hold
4yr
Exit
2017
to Advanced Enzyme Technologies
BRAIN Biotech
MIG Fonds 5
GermanySector
Biotech
InvestorMIG Capital
Entry
2006
Hold
10yr
Exit
2016
Ganymed Pharmaceuticals
MIG Fonds 5
GermanySector
Biotech
InvestorMIG Capital
Entry
2001
Hold
15yr
Owners
2
Exit
2016
to Astellas Pharma
B.R.A.I.N. AG
Technologiefonds Hessen
GermanySector
Biotech
InvestorBMH Beteiligungsmanagement Hessen
Entry
2014
Hold
2yr
Exit
2016
BioGenes
VC Fonds Technologie Berlin
GermanySector
Biotech
InvestorIBB Ventures
Entry
2003
Hold
12yr
Exit
2015
to Alexander Knoll and Sergej Ovodov
SuppreMol
MIG Fonds 5
GermanySector
Biotech
InvestorMIG Capital
Entry
2006
Hold
9yr
Owners
2
Exit
2015
to Baxter
Phenex
LBBW VC Evergreen Vehicle
GermanySector
Biotech
InvestorLBBW Venture Capital
Entry
2005
Hold
10yr
Exit
2015
to Gilead Sciences
Pieris Pharmaceuticals
Seedfonds Bayern
GermanySector
Biotech
InvestorBayern Kapital
Entry
2001
Hold
14yr
Exit
2015
Corimmun
HTGF I
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2006
Hold
6yr
Exit
2012
to Janssen (Johnson & Johnson)
KINAXO
HTGF I
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2006
Hold
5yr
Exit
2011
to Evotec AG
Jerini
HealthCap V
GermanySector
Biotech
InvestorHealthCap
Entry
2000
Hold
8yr
Owners
3
Exit
2008
to Shire
evotec
Haspa BGM Evergreen
GermanySector
Biotech
InvestorHaspa Beteiligungsgesellschaft
Entry
1998
Hold
7yr
Exit
2005